Irradiation-Induced Regulation of Plasminogen Activator Inhibitor Type-1 and Vascular Endothelial Growth Factor in Six Human Squamous Cell Carcinoma Lines of the Head and Neck

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 574-582

  Artman, Tuuli ^a   Schilling, Daniela ^a   Gnann, Julia ^a   Molls, Michael ^a   Multhoff, Gabriele ^a   Bayer, Christine ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hypoxia inducible factor (HIF); Irradiation; Plasminogen activator inhibitor type 1 (PAI 1); Squamous cell carcinoma of the head and neck (SCCHN); Transforming growth factor 1 (TGF 1); Vascular endothelial growth factor (VEGF)

Indexed keywords

HYPOXIA-INDUCIBLE FACTOR (HIF); HYPOXIA-INDUCIBLE FACTORS; PLASMINOGEN ACTIVATOR INHIBITOR; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; TRANSFORMING GROWTH FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOACTIVITY; CELL CULTURE; CELLS; ENZYME INHIBITION; IRRADIATION; PEPTIDES; SELF ASSEMBLY;

RADIATION;

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL ACTIVITY; CELL METABOLISM; CELL STRAIN FADU; CELL STRAIN XF354; CLONOGENIC ASSAY; COLORIMETRY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; UPREGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; COLORIMETRY; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PLASMINOGEN ACTIVATOR INHIBITOR 1; RADIATION TOLERANCE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73649115987     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.035     Document Type: Article

References (32)

1. Hovinga K.E., Stalpers L.J., van B.C., et al. Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines-a clue to radioresistance?. J Neurooncol 74 (2005) 99-103
2. Gorski D.H., Beckett M.A., Jaskowiak N.T., et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59 (1999) 3374-3378
3. Parikh R.R., Yang Q., and Haffty B.G. Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy. Cancer 109 (2007) 566-573
4. Manders P., Sweep F.C., Tjan-Heijnen V.C., et al. Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. Clin Cancer Res 9 (2003) 6363-6370
5. Smith B.D., Smith G.L., Carter D., et al. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18 (2000) 2046-2052
6. Aebersold D.M., Beer K.T., Laissue J., et al. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48 (2000) 17-25
7. Manders P., Beex L.V., Tjan-Heijnen V.C., et al. Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients. Int J Oncol 25 (2004) 511-517
8. Bajou K., Masson V., Gerard R.D., et al. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152 (2001) 777-784
9. Pepper M.S., Belin D., Montesano R., et al. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111 (1990) 743-755
10. Hjortland G.O., Lillehammer T., Somme S., et al. Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells. Exp Cell Res 294 (2004) 130-139
11. Swiatkowska M., Szemraj J., Al-Nedawi K.N., and Pawlowska Z. Reactive oxygen species upregulate expression of PAI-1 in endothelial cells. Cell Mol Biol Lett 7 (2002) 1065-1071
12. Zhao W., Spitz D.R., Oberley L.W., and Robbins M.E. Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation. Cancer Res 61 (2001) 5537-55343
13. Hageman J., Eggen B.J., Rozema T., et al. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 11 (2005) 5956-5964
14. Schilling D., Bayer C., Geurts-Moespot A., et al. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines. BMC Cancer 7 (2007) 143
15. Angenete E., Langenskiold M., Palmgren I., et al. uPA and PAI-1 in rectal cancer-relationship to radiotherapy and clinical outcome. J Surg Res (2008)
16. Bayer C., Schilling D., Hoetzel J., et al. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother Oncol 86 (2008) 361-368
17. Yaromina A., Krause M., Thames H., et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol 83 (2007) 304-310
18. Sugano Y., Matsuzaki K., Tahashi Y., et al. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Oncogene 22 (2003) 2309-2321
19. Gorski D.H., Beckett M.A., Jaskowiak N.T., et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59 (1999) 3374-3378
20. Park J.S., Qiao L., Su Z.Z., et al. Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene 20 (2001) 3266-3280
21. Zhao W., O'Malley Y., Wei S., and Robbins M.E. Irradiation of rat tubule epithelial cells alters the expression of gene products associated with the synthesis and degradation of extracellular matrix. Int J Radiat Biol 76 (2000) 391-402
22. Brown C.K., Khodarev N.N., Yu J., et al. Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Lett 565 (2004) 167-170
23. Gupta V.K., Jaskowiak N.T., Beckett M.A., et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J 8 (2002) 47-54
24. Hess C., Vuong V., Hegyi I., et al. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer 85 (2001) 2010-2016
25. Bajou K., Maillard C., Jost M., et al. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23 (2004) 6986-6990
26. Kaminska B., Wesolowska A., and Danilkiewicz M. TGF beta signalling and its role in tumour pathogenesis. Acta Biochim Pol 52 (2005) 329-337
27. Sawdey M., Podor T.J., and Loskutoff D.J. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem 264 (1989) 10396-10401
28. Benckert C., Jonas S., Cramer T., et al. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63 (2003) 1083-1092
29. Sugano Y., Matsuzaki K., Tahashi Y., et al. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Oncogene 22 (2003) 2309-2321
30. Wesolowska A., Kwiatkowska A., Slomnicki L., et al. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 27 (2008) 918-930
31. Moeller B., Cao Y., Li C., and Dewhirst. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (2004) 429-444
32. Moeller B., Dreher M., Rabbani Z., et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8 (2005) 99-110